This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clifton, V. L. Articles by Wright, I. M. R. Search for Related Content PubMed PubMed Citation Articles by Clifton, V. L. Articles by Wright, I. M. R.

Microvascular Effects of CRH in Human Skin Vary in Relation to Gender

Mothers and Babies Research Centre, John Hunter Hospital, University of Newcastle, Newcastle, New South Wales, Australia 2310

Address all correspondence and requests for reprints to: Dr. Ian Wright, Neonatal Intensive Care Unit, John Hunter Hospital, Locked Bag #1, Hunter Region Mail Center, Newcastle, New South Wales 2310, Australia. E-mail: iwright{at}mail.newcastle.edu.au

Males and females have a significantly different life expectancy because of the cardioprotective effects of estrogen. The mechanisms that result in this difference between the sexes are not fully understood. However, stress is a contributing factor to the development of cardiovascular disease, and stress-related factors derived from central or peripheral sources may have differential effects in the modulation of cardiovascular function in males and females. CRH is a central modulator of the stress response and is known to have vasodilator effects in a number of vascular beds. We have examined whether CRH has vasodilator effects in human skin and whether this effect is different between males and females using laser Doppler and iontophoresis. CRH (1 nM) had vasodilatory effects in the skin circulation of both premenopausal females (n = 6) and age-matched males (n = 5), but CRH-induced dilation was significantly more potent in females than males. Acetylcholine-(1 nM) and sodium nitroprusside- (0.74 nM) induced dilation was not significantly different between males (n = 6) and females (n = 6). This is the first study to demonstrate that CRH acts locally as a vasodilator in human skin circulation and that this response is augmented in premenopausal females. The mechanism by which CRH causes dilation in human skin is presently unknown. However, these data suggest that CRH-induced dilation may be one mechanism by which cardiovascular risk is reduced in premenopausal women.

This work was supported by grants from the John Hunter Hospital Charitable Foundation.

Abbreviations: NO, Nitric oxide; PU, perfusion unit.

This article has been cited by other articles:

				M. J. Stark, L. Dierkx, V. L. Clifton, and I. M. R. Wright Alterations in the Maternal Peripheral Microvascular Response in Pregnancies Complicated by Preeclampsia and the Impact of Fetal Sex Reproductive Sciences, December 1, 2006; 13(8): 573 - 578. [Abstract] [PDF]

				T. C THEOHARIDES and D. KALOGEROMITROS The Critical Role of Mast Cells in Allergy and Inflammation Ann. N.Y. Acad. Sci., November 1, 2006; 1088(1): 78 - 99. [Abstract] [Full Text] [PDF]

				J. Donelan, W. Boucher, N. Papadopoulou, M. Lytinas, D. Papaliodis, P. Dobner, and T. C. Theoharides Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process PNAS, May 16, 2006; 103(20): 7759 - 7764. [Abstract] [Full Text] [PDF]

				V L Clifton, R Crompton, M A Read, P G Gibson, R Smith, and I M R Wright Microvascular effects of corticotropin-releasing hormone in human skin vary in relation to estrogen concentration during the menstrual cycle J. Endocrinol., July 1, 2005; 186(1): 69 - 76. [Abstract] [Full Text] [PDF]

				P. Florio, A. Imperatore, F. Sanseverino, M. Torricelli, F. M. Reis, P. J. Lowry, and F. Petraglia The Measurement of Maternal Plasma Corticotropin-Releasing Factor (CRF) and CRF-Binding Protein Improves the Early Prediction of Preeclampsia J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4673 - 4677. [Abstract] [Full Text] [PDF]

				D. Kempuraj, N. G. Papadopoulou, M. Lytinas, M. Huang, K. Kandere-Grzybowska, B. Madhappan, W. Boucher, S. Christodoulou, A. Athanassiou, and T. C. Theoharides Corticotropin-Releasing Hormone and Its Structurally Related Urocortin Are Synthesized and Secreted by Human Mast Cells Endocrinology, January 1, 2004; 145(1): 43 - 48. [Abstract] [Full Text] [PDF]

				R. Crompton, V. L. Clifton, A. T. Bisits, M. A. Read, R. Smith, and I. M. R. Wright Corticotropin-Releasing Hormone Causes Vasodilation in Human Skin via Mast Cell-Dependent Pathways J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5427 - 5432. [Abstract] [Full Text] [PDF]